P3 Health Partners Revenue 2020-2024 | PIII
P3 Health Partners revenue from 2020 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| P3 Health Partners Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $1,266 |
| 2022 | $1,049 |
| 2021 | $637 |
| 2020 | $491 |
| 2019 | $145 |
| P3 Health Partners Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-09-30 | $362 |
| 2024-06-30 | $379 |
| 2024-03-31 | $388 |
| 2023-12-31 | $347 |
| 2023-09-30 | $288 |
| 2023-06-30 | $329 |
| 2023-03-31 | $302 |
| 2022-12-31 | $258 |
| 2022-09-30 | $248 |
| 2022-06-30 | $269 |
| 2022-03-31 | $274 |
| 2021-12-31 | $185 |
| 2021-09-30 | $156 |
| 2021-06-30 | $145 |
| 2021-03-31 | $151 |
| 2020-12-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.065B | $1.266B |
| P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.870B | 55.80 |
| Tempus AI (TEM) | United States | $9.036B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $8.145B | 207.11 |
| Inspire Medical Systems (INSP) | United States | $5.799B | 180.84 |
| IRhythm Technologies (IRTC) | United States | $3.407B | 0.00 |
| Privia Health (PRVA) | United States | $2.742B | 228.50 |
| Enovis (ENOV) | United States | $2.671B | 17.80 |
| Azenta (AZTA) | United States | $2.470B | 131.83 |
| Clover Health Investments (CLOV) | United States | $2.200B | 0.00 |
| Omnicell (OMCL) | United States | $2.084B | 68.17 |
| Schrodinger (SDGR) | United States | $1.827B | 0.00 |
| 10x Genomics (TXG) | United States | $1.816B | 0.00 |
| Phreesia (PHR) | United States | $1.654B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.850B | 0.00 |
| Standard BioTools (LAB) | United States | $0.577B | 0.00 |
| Talkspace (TALK) | United States | $0.524B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.509B | 0.00 |
| TruBridge (TBRG) | United States | $0.370B | 107.91 |
| Nyxoah SA (NYXH) | Belgium | $0.368B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.343B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.229B | 0.00 |
| Pulmonx (LUNG) | United States | $0.224B | 0.00 |
| American Well (AMWL) | United States | $0.165B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.090B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.087B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| CareCloud (CCLD) | United States | $0.056B | 0.00 |
| 111 (YI) | China | $0.050B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.047B | 0.00 |
| Outset Medical (OM) | United States | $0.043B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.035B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.020B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |